Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 12, 2000, Pages 3264-3271

  Giamarellou, H ^a   Bassaris, H P ^a   Petrikkos, G ^a   Busch, W ^a   Voulgarelis, M ^a   Antoniadou, A ^a   Grouzi, E ^a   Zoumbos, N ^a  

^a SISMANOGLIO HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTAZIDIME; CIPROFLOXACIN;

ADULT; AGED; ARTICLE; BACTEREMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYSTALLURIA; DRUG EFFICACY; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OTOTOXICITY; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGRANULOCYTOSIS; AMIKACIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CEFTAZIDIME; CEPHALOSPORINS; CIPROFLOXACIN; DRUG THERAPY, COMBINATION; FEMALE; FEVER; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0034426121     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.12.3264-3271.2000     Document Type: Article

References (30)

1. A prospective randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever
2. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia
3. Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients
4. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer
5. Criteria for response in patients in clinical trials of empiric antibiotic regimens for febrile neutropenia. Is there agreement?
6. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy
7. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
8. The design, analysis and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of the consensus panel
9. Grampositive bacteremia in granulocytopenic cancer patient
10. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia
11. A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients
12. Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linezolid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains
13. Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients
14. A comparative study of intravenous ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin for the empirical treatment of fever in neutropenic patients
15. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy
16. Febrile neutropenia
17. Science and pragmatism in the treatment and prevention of neutropenic infection
18. Clinical significance of in vitro synergism between antibiotics in gram-negative infections
19. Synergistic combinations of antibiotics in gram-negative bacillary infections
20. Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors
21. The changing pattern of infection in neutropenic patients
22. Clinical trials on the empirical antibiotic management of the neutropenic patient
23. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia
24. Is monotherapy for febrile neutropenia still a viable alternative?
25. A comparison of imipenem to ceftazidime with and without amikacin as empiric therapy in febrile neutropenic patients
26. Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients: A meta-analysis
27. The evaluation of the empirical management of fever and neutropenia in cancer patients
28. Fluoroquinolone antimicrobial agents
29. Changing epidemiology of infections in patients with neutropenia and cancer: Emphasis on gram-positive and resistant bacteria